Stay updated on Inhibitors for COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Inhibitors for COVID-19 Clinical Trial page.

Latest updates to the Inhibitors for COVID-19 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded explicit study-site details (five locations: Leeds; London—two sites; Reading; Sheffield) with the associated NHS Trusts. Clarified the primary outcome definitions for MATIS and linked related study documents (Protocol, SAP) and data-sharing information.SummaryDifference7%

- Check28 days agoChange DetectedThe government funding/operating status notice banner has been removed from the page; it previously informed users that information may not be up to date and pointed to operating status resources. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedMinor wording and formatting updates appear in the Study Overview and Contacts/Locations sections; core trial content such as eligibility criteria, treatment arms, and primary outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference3%

- Check78 days agoChange DetectedUpdated contact details and revision version from v3.0.2 to v3.1.0; new phone numbers and email added, old revision tag removed.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed. No changes to core content, pricing, or availability.SummaryDifference0.2%

Stay in the know with updates to Inhibitors for COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhibitors for COVID-19 Clinical Trial page.